UCFA
JAZZ icon

United Capital Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

United Capital Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,769
Closed -$264K – 1287
2019
Q4 		$264K Buy
1,769
+62
+4% +$8.44K ﹤0.01% 1188
2019
Q3 		$219K Sell
1,707
-2,120
-55% -$284K ﹤0.01% 1166
2019
Q2 		$546K Buy
3,827
+1,821
+91% +$245K ﹤0.01% 1021
2019
Q1 		$287K Buy
2,006
+132
+7% +$17.2K ﹤0.01% 1140
2018
Q4 		$232K Sell
1,874
-199
-10% -$29.5K ﹤0.01% 1155
2018
Q3 		$349K Buy
2,073
+370
+22% +$63.6K ﹤0.01% 1055
2018
Q2 		$293K Sell
1,703
-1,052
-38% -$172K ﹤0.01% 1086
2018
Q1 		$416K Buy
2,755
+147
+6% +$21.6K ﹤0.01% 999
2017
Q4 		$351K Sell
2,608
-51
-2% -$7.07K ﹤0.01% 1062
2017
Q3 		$389K Sell
2,659
-100
-4% -$15.1K ﹤0.01% 1034
2017
Q2 		$429K Buy
2,759
+66
+2% +$10.1K ﹤0.01% 969
2017
Q1 		$391K Sell
2,693
-518
-16% -$67.5K ﹤0.01% 969
2016
Q4 		$350K Sell
3,211
-7,743
-71% -$862K ﹤0.01% 1006
2016
Q3 		$1.33M Sell
10,954
-1,104
-9% -$149K 0.01% 700
2016
Q2 		$1.7M Buy
12,058
+177
+1% +$26.1K 0.02% 593
2016
Q1 		$1.55M Sell
11,881
-1,559
-12% -$194K 0.02% 589
2015
Q4 		$1.89M Sell
13,440
-1,601
-11% -$222K 0.02% 557
2015
Q3 		$2M Buy
15,041
+11,172
+289% +$1.92M 0.02% 526
2015
Q2 		$681K Buy
3,869
+314
+9% +$56.4K 0.01% 817
2015
Q1 		$635K Buy
3,555
+100
+3% +$17.2K 0.01% 819
2014
Q4 		$566K Buy
3,455
+950
+38% +$158K 0.01% 785
2014
Q3 		$402K Buy
+2,505
New +$385K 0.01% 851
2014
Q2 		– Sell
-7,457
Closed -$1.03M – 875
2014
Q1 		$1.03M Buy
+7,457
New +$1.12M 0.02% 485

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

United Capital Financial Advisors's JAZZ Position: Q1 2020 in Review

United Capital Financial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 1,769 shares — an estimated $264K sold.

United Capital Financial Advisors first reported a position in JAZZ in Q1 2014 and held it in 23 quarters. The position peaked at $2M in Q3 2015. 408 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • United Capital Financial Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • United Capital Financial Advisors sold 1,769 Jazz Pharmaceuticals shares in Q1 2020, an estimated $264K.
  • United Capital Financial Advisors first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 23 quarters.
  • United Capital Financial Advisors's Jazz Pharmaceuticals position peaked at $2M in Q3 2015.
  • 408 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on United Capital Financial Advisors's 13F filing for Q1 2020, filed 15 May 2020.